Daniel G. Chaves

Belo Horizonte, MG, Brazil

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 37 publications

Corrigendum to 'Deleterious variants cluster in the A3 domain of factor VIII in people with severe hemophilia A and inhibitors': [Research and Practice in Thrombosis and Haemostasis Volume 9, Issue 6, August 2025, 103006].

Corrigendum to 'Deleterious variants cluster in the A3 domain of factor VIII in people with severe hemophilia A and inhibitors': [Research and Practice in Thrombosis and Haemostasis Volume 9, Issue 6, August 2025, 103006].

Journal: Research and practice in thrombosis and haemostasis

Published: February 18, 2026

Deleterious variants cluster in the A3 domain of factor VIII in people with severe hemophilia A and inhibitors.

Deleterious variants cluster in the A3 domain of factor VIII in people with severe hemophilia A and inhibitors.

Journal: Research and practice in thrombosis and haemostasis

Published: May 12, 2025

Genomic ancestry, F8 variants, and immune tolerance in hemophilia A patients with inhibitors: exome sequencing insights.

Genomic ancestry, F8 variants, and immune tolerance in hemophilia A patients with inhibitors: exome sequencing insights.

Journal: Haematologica

Published: December 20, 2024

Large deletions and small insertions and deletions in the factor VIII gene predict unfavorable immune tolerance induction outcome in people with severe hemophilia A and high-responding inhibitors.

Large deletions and small insertions and deletions in the factor VIII gene predict unfavorable immune tolerance induction outcome in people with severe hemophilia A and high-responding inhibitors.

Journal: Thrombosis research

Published: May 11, 2024

HLA variants and inhibitor development in hemophilia A: results from the HEMFIL study group.

HLA variants and inhibitor development in hemophilia A: results from the HEMFIL study group.

Journal: Hematology, transfusion and cell therapy

Published: May 09, 2024

High levels of anti-factor VIII immunoglobulin G4 and immunoglobulin G total are associated with immune tolerance induction failure in people with congenital hemophilia A and high-responding inhibitors.

High levels of anti-factor VIII immunoglobulin G4 and immunoglobulin G total are associated with immune tolerance induction failure in people with congenital hemophilia A and high-responding inhibitors.

Journal: Research and practice in thrombosis and haemostasis

Published: March 25, 2024

Prediction of inhibitor development in previously untreated and minimally treated children with severe and moderately severe hemophilia A using a machine-learning network.

Prediction of inhibitor development in previously untreated and minimally treated children with severe and moderately severe hemophilia A using a machine-learning network.

Journal: Journal of thrombosis and haemostasis : JTH

Published: February 04, 2024

Germline variants of the immune checkpoint proteins PD-1, PD-l1 and CTLA-4 and immune tolerance induction outcome in patients with inherited haemophilia A.

Germline variants of the immune checkpoint proteins PD-1, PD-l1 and CTLA-4 and immune tolerance induction outcome in patients with inherited haemophilia A.

Journal: Haemophilia : the official journal of the World Federation of Hemophilia

Published: March 29, 2023

Phenotypic variation in severe hemophilia A is related to endogenous thrombin potential and plasma levels of factor VII.

Phenotypic variation in severe hemophilia A is related to endogenous thrombin potential and plasma levels of factor VII.

Journal: Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis

Published: November 21, 2022

Prevalence of sporadic haemophilia A.

Prevalence of sporadic haemophilia A.

Journal: Haemophilia : the official journal of the World Federation of Hemophilia

Published: October 11, 2022

A potent inflammatory response is triggered in asymptomatic blood donors with recent SARS-CoV-2 infection.

A potent inflammatory response is triggered in asymptomatic blood donors with recent SARS-CoV-2 infection.

Journal: Revista da Sociedade Brasileira de Medicina Tropical

Published: May 03, 2022

SARS-CoV-2 IgG Seroprevalence among Blood Donors as a Monitor of the COVID-19 Epidemic, Brazil.

SARS-CoV-2 IgG Seroprevalence among Blood Donors as a Monitor of the COVID-19 Epidemic, Brazil.

Journal: Emerging infectious diseases

Published: February 18, 2022

Showing 1-12 of 37

Last Updated: 09/26/2026